Viewing Study NCT06450925



Ignite Creation Date: 2024-06-16 @ 11:52 AM
Last Modification Date: 2024-10-26 @ 3:31 PM
Study NCT ID: NCT06450925
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-06-11
First Post: 2024-06-05

Brief Title: Vitamin A Supplementation in Allogeneic Stem Cell Transplantation
Sponsor: Childrens Hospital Medical Center Cincinnati
Organization: Childrens Hospital Medical Center Cincinnati

Study Overview

Official Title: A Randomized Double Blinded Trial of Vitamin A Supplementation in Allogeneic Stem Cell Transplantation
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The investigators hypothesize that single oral high dose supplementation with vitamin A will reduce the incidence of moderate-severe chronic graft-versus-host disease GVHD compared with placebo
Detailed Description: Hematopoietic stem cell transplantation HSCT is an effective treatment strategy for many malignancies marrow failure syndromes and immune deficiencies in children adolescents and adults Vitamin A and its derivatives regulate growth and differentiation of intestinal cells and vitamin A deficiency is associated with increased susceptibility to infection in both human and animal models The investigators preliminary data suggest lower vitamin A levels were associated with an increased incidence of gastrointestinal graft versus host disease GI GVHD in patients undergoing HSCT

This study is a randomized double blinded comparison of vitamin A supplementation comparing a single large dose of vitamin A with a placebo

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None